Literature DB >> 2393299

The involvement of carnitine intermediates in peroxisomal fatty acid oxidation: a study with 2-bromofatty acids.

K F Buechler1, J M Lowenstein.   

Abstract

Metabolism-dependent inactivators of 3-ketothiolase I and carnitine acyltransferase I (CAT I) have been used to study the oxidation of fatty acids in intact hepatocytes. 2-Bromooctanoate inactivates mitochondrial and peroxisomal 3-ketothiolases I in a time-dependent manner. During the first 5 min of incubation, inactivation of 3-ketothiolase in mitochondria is five times faster than its inactivation in peroxisomes. Almost complete inactivation of 3-ketothiolase I in both types of organelle is achieved after incubation with 1 mM 2-bromooctanoate for 40 min. The inactivation is not affected by preincubating hepatocytes with 20 microM tetradecylglycidate (TDGA), an inactivator of CAT I, under conditions which cause greater than 95% inactivation of CAT I. 2-Bromododecanoate (1 mM) causes 60% inactivation of mitochondrial and peroxisomal 3-ketothiolases I in 40 min. These inactivations are greatly reduced by preincubating hepatocytes with 20 microM TDGA, demonstrating that 2-bromododecanoate enters both mitochondria and peroxisomes via its carnitine ester. 2-Bromopalmitate (1 mM) causes less than 5% inactivation of mitochondrial and peroxisomal 3-ketothiolases I in 40 min, but causes 95% inactivation of CAT I during this time. Incubation of hepatocytes with 10-200 microM 2-bromopalmitoyl-L-carnitine causes inactivation of mitochondrial and peroxisomal 3-ketothiolases I at similar rates. This inactivation is decreased by palmitoyl-D-carnitine during the first 5 min of incubation. Pretreating hepatocytes with 20 microM TDGA does not affect the inactivation of mitochondrial or peroxisomal 3-ketothiolase I by 2-bromopalmitoyl-L-carnitine. These results demonstrate that in intact hepatocytes, peroxisomes oxidize fatty acids of medium-chain length by a carnitine-independent mechanism, whereas they oxidize long-chain fatty acids by a carnitine-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393299     DOI: 10.1016/0003-9861(90)90437-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Activity of carnitine palmitoyltransferase in mitochondrial outer membranes and peroxisomes in digitonin-permeabilized hepatocytes. Selective modulation of mitochondrial enzyme activity by okadaic acid.

Authors:  M Guzmán; M J Geelen
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Involvement of carnitine acyltransferases in peroxisomal fatty acid metabolism by the yeast Pichia guilliermondii.

Authors:  Y Pagot; J M Belin
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

3.  Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue.

Authors:  Giovanni Pistone; Angela Marino; Carmelo Leotta; Simona Dell'Arte; Giovanna Finocchiaro; Mariano Malaguarnera
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 4.  Liver pathology and immunocytochemistry in congenital peroxisomal diseases: a review.

Authors:  F Roels; M Espeel; D De Craemer
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

5.  Peroxisomal localization of the immunoreactive beta-oxidation enzymes in a neonate with a beta-oxidation defect. Pathological observations in liver, adrenal cortex and kidney.

Authors:  M Espeel; F Roels; L Van Maldergem; D De Craemer; G Dacremont; R J Wanders; T Hashimoto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Profiling targets of the irreversible palmitoylation inhibitor 2-bromopalmitate.

Authors:  Dahvid Davda; Mahmoud A El Azzouny; Christopher T M B Tom; Jeannie L Hernandez; Jaimeen D Majmudar; Robert T Kennedy; Brent R Martin
Journal:  ACS Chem Biol       Date:  2013-07-25       Impact factor: 5.100

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.